Cargando…
Association of body mass and systemic immune-inflammation indices with endocrine therapy resistance in luminal breast cancers
OBJECTIVE: To explore correlations between body mass index (BMI), preoperative systemic immune-inflammation index (SII) and endocrine therapy resistance, and evaluate BMI and SII as predictors of resistance, in patients with luminal breast cancer. METHODS: This retrospective study included patients...
Autores principales: | Li, Qing-xia, Shi, Dong-jian, Zhang, Li-xia, Wang, Dong-miao, Zhao, Jing, Wang, Tao, Deng, Xin-na, Fan, Xiao-yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567779/ https://www.ncbi.nlm.nih.gov/pubmed/30843447 http://dx.doi.org/10.1177/0300060519831570 |
Ejemplares similares
-
Is There a Correlation between the Presence of a Spiculated Mass on Mammogram and Luminal A Subtype Breast Cancer?
por: Liu, Song, et al.
Publicado: (2016) -
Molecular Mechanism of Secondary Endocrine Resistance in Luminal Breast Cancer
por: Wu, Minhua, et al.
Publicado: (2021) -
TET2 directs mammary luminal cell differentiation and endocrine response
por: Kim, Mi Ran, et al.
Publicado: (2020) -
Anterior segment structure changes caused by different luminance light after implantable collamer lens surgery
por: Li, Xia, et al.
Publicado: (2023) -
Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests
por: Saponaro, Mariarosaria, et al.
Publicado: (2022)